Which document demonstrates that regulatory authorities have authorized/approved/notified the protocol prior to initiation of regulatory requirements?

Which document demonstrates that regulatory authorities have authorized/approved/notified the protocol prior to initiation of regulatory requirements?

• A. Normal Values/Ranges for Medical/Laboratory/Technical Procedures and/or Tests Included in the Protocol
• B. Regulatory Authorities Authorization/Approval/Notification of Protocol
• C. Medical/Laboratory/Technical Procedures/Tests
• D. Sample of Labels Attached to Investigational Product Containers

Answer: (B)

Formal regulatory clearance before starting a trial is shown by the regulatory authority’s authorization, approval, or a formal notification of the protocol. This official document confirms that the protocol has been reviewed for safety, scientific validity, and ethical considerations and that regulatory requirements have been addressed prior to proceeding. The other options don’t serve that function. Normal values or ranges pertain to interpreting results, not to regulatory clearance. A document describing medical, laboratory, or technical procedures is about how tests are performed, not about regulatory authorization. A sample of labels attached to investigational product containers relates to labeling compliance, not to approval of the protocol itself.

Formal regulatory clearance before starting a trial is shown by the regulatory authority’s authorization, approval, or a formal notification of the protocol. This official document confirms that the protocol has been reviewed for safety, scientific validity, and ethical considerations and that regulatory requirements have been addressed prior to proceeding.

The other options don’t serve that function. Normal values or ranges pertain to interpreting results, not to regulatory clearance. A document describing medical, laboratory, or technical procedures is about how tests are performed, not about regulatory authorization. A sample of labels attached to investigational product containers relates to labeling compliance, not to approval of the protocol itself.